At the Right Weight Center, we understand the challenges of weight loss and offer personalized care to align with your unique needs
At the very least, your doctor should be in line with the NICE and BNF guidelines
These trials would evaluate safety, establish effective dosing, and measure fat loss and other outcomes under controlled conditions
Subcutaneous injection delivers the compound into the interstitial space, from which it diffuses into capillaries and enters systemic circulation without passing through the hepatic portal system first
Table of Contents What Is Retatrutide and Its Role in Weight Loss Treatment Understanding Retatrutide Reconstitution: Important Safety Information Reconstitution Calculators: Why They Are Not Appropriate for Patient Use Dosing Considerations and MHRA Safety Guidance Risks of Incorrect Reconstitution and When to Seek Advice Accessing Weight Loss Medicines Safely Through UK Healthcare Scientific References Frequently Asked Questions What Is Retatrutide and Its Role in Weight Loss Treatment Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) not yet licensed by the MHRA or EMA, meaning it cannot legally be prescribed or supplied as a medicine in the UK outside approved clinical trials